A comparison was made of the T antigens induced in transformed cells or infected permissive cells by representatives of three categories of human papovavirus. The transformed hamster cell lines employed contained T antigen induced by either the BK or RF strains of papovavirus associated with human renal allografts; the JC strain of papovavirus from progressive multifocat leukoencephalopathy (PML), or a variant of SV4o virus isolated from PML. The human papovavirus T antigens were also compared with that of a human cell line transformed by SV4o of simian origin. Anti-T antibody prepared in hamsters against each of the hamster cell lines was absorbed with crude T antigen from each cell /ine, and the unabsorbed and absorbed antisera were tested for residual T antibody against each cell line, or against infected permissive cells by immunoperoxidase (IP) staining and complement-fixation (CF) tests.
INTRODUCTION
Human papovaviruses have been isolated from urine of immunosuppressed recipients of renal allografts (Gardner et aL I97t; Coleman, Gardner & Field, 1973; Dougherty & DiStefano, 1974; Jung et al. 1975; Lecatsas & Prozesky, 1975) or urine of patients receiving chemotherapy for malignancy (Reese et al. I975) and from the brains of patients with progressive multifocal leukoencephalopathy (PML; Padgett et aL 1971 ; Weiner et al. 1972; Castaigne et al. I973; Weiner et al. 1973; Field et al. I974 )-The viruses fall into three subgroups on the basis of serology, host range and DNA structure. Two isolates from the brains of PML patients appear to be nearly identical to the simian papovavirus, SV4o (Sack et al. 1973; Narayan & Weiner, r974) . JC virus, which was also recovered from PML (Padgett et al. I97I) , is distinct from SV4o and the viruses that occur in urine of immunosuppressed individuals. The third subgroup, mostly isolated from urine, of which BK virus is the prototype (Gardner et al. 1970 , differs antigenically and in DNA structure from the PML-associated viruses and SV4o (Penney & Narayan, I973; Takemoto & Mullarkey, 1973; Mullarkey, Hruska & Takemoto, 1974; Osbourn et al. 1974) . Isolates from urine and a brain tumour of patients with Wiskott-Aldrich syndrome resemble the renal BK virus (Takemoto et al. 1974) . Comparison of five isolates from urine, which were obtained in widely separated localities, showed them to be closely similar antigenically and to have similar in vitro oncogenic potential; only minor strain differences were detected by analysis of tryptic peptides of some virion proteins (Wright et al. 1976) .
Viruses from each of the 3 subgroups are oncogenic. JC virus induced malignant gliomas in newborn hamsters (Walker et al. 1973 ) and the two strains of SV4o isolated from PML induced sarcomas or choroid plexus papillomas in hamsters (Narayan & Weiner, 1974) . The BK and RF strains of human papovavirus induced malignant transformation of hamster cells in vitro (Major & di Mayorca, 1973; Portolani, Barbanti-Brodano & La Placa, 1975; Dougherty, 1976; Takemoto & Martin, 1976) and sarcomas in hamsters (Nase, K/irkk/iinen & M/intyjiirvi, 1975; Shah, Daniel & Strandberg, 1975; Dougherty, 1976 ) .
T antigens that cross-react with SV4o T antigen have been described in cell lines transformed in vivo or in vitro by JC virus (Walker et al. I973) , PML-derived SV4o virus (Narayan & Weiner, 1974) and the BK and RF strains of human papovavirus (Nfise et al. 1975; Portolani et al. 1975; Dougherty, 1976; Takemoto & Martin, ~976) . The T antigen associated with RF virus-transformed cells cross-reacted with SV4o T antigen, but the two antigens were shown to be distinct by the use of suitably absorbed antisera (Dougherty, 1976) . The purpose of this study was to compare the T antigens of human papovaviruses representative of the 3 subgroups (JC, PML-associated SV4o, and BK). The results show that the T antigens of each group are distinctive.
METHODS
Viruses. The RF strain of human papovavirus was isolated from urine of a renal transplant patient as described previously (Dougherty & DiStefano, 1974) . The BK strain (Gardner et al. I971) was supplied by Dr G. di Mayorca. Stock virus was obtained from 5th passage human embryo kidney (HEK) cell cultures showing 50 to 8o ~ cell destruction 7 to 9 days after infection with an input multiplicity of approx, o.oi. A crude homogenate of cells and fluid was stored at -70 °C. A large-plaque isolate of SV4o virus (LP-4), obtained from Dr Leila Diamond, was grown in the CV-I line of African Green monkey kidney cells. Stocks were prepared as described above.
Cell cultures. Cell cultures were grown in Petri dishes in a humidified CO2 incubator at 37 °C in medium composed of Eagles minimal essential medium with IO ~ tryptose phosphate broth (Difco), 8 ~ calf serum and 7 ~ foetal calf serum. HEK cells were purchased as trypsinized cell suspensions and were generally used after 5 passages in culture. The CV-I cells were obtained from Dr Diamond and were passaged at I to 5 twice weekly. The origins of the papovavirus-transformed cell lines used in this study are described below. All of the transformed cells grew rapidly and required transfer every 3 or 4 days at I to I0 or I to 20. Antisera. Antisera against papovavirus T antigens were made in hamsters with tumours induced by transplantation of cultured virus-transformed hamster cells. Outbred Syrian hamsters, purchased as weanlings from Lakeview Hamster Colony, were injected sub-cutaneously on the back with 0"3 ml of Earle's balanced salt solution (BSS) containing 5 x io 5 freshly trypsinized tissue culture cells. All of the hamster cell lines induced subcutaneous tumours in the majority of animals. Blood was collected 3 to 4 mouths later and screened for the presence of T antibody by immunoperoxidase staining against the cells used to induce the tumour.
Immunoperoxidase (IP) staining. The unlabelled antibody-enzyme method (Sternberger et al. I97o ) was employed to demonstrate virus antigens. Details of the method and preparation of reagents were described elsewhere (Dougherty, Marucci & DiStefano, 2972) . Cell cultures grown on coverslips were first washed for 3 min in Earle's BSS buffered at pH 7"3 with 0"05 M-tris-HC1. The washed cells were transferred to 95 ~o ethanol for 5 min, then to acetone for 5 min. The fixed cells were washed in oq5 M-NaCI buffered at pH 7"3 with o.o5-M-tris-HC1 (TBS). To demonstrate T antigen, coverslips were flooded for so min with hamster anti-T antiserum diluted I/m in TBS. The coverslips were washed in 3 changes of TBS, 3 rain each, and then flooded with a ~/~o dilution in TBS of hyperimmune rabbit anti-hamster globulin. After washing as above, the coverslips were treated with a 2/50 dilution in TBS of a soluble immune complex of horseradish peroxidase and hamster antiperoxidase (PAP) and again washed. To summarize the immunological events of this procedure, hamster anti-T antibodies combined with T antigen in the cells. Rabbit anti-hamster globulin, which was in antibody excess, combined with the bound hamster globulin by only one active site, leaving one antiglobulin site free to react with antigentic determinants of the hamster immunogIobulin component of PAP. Peroxidase was thus localized at the sites of T antigen. The cells were re-fixed for 2o min in 2 ~ glutaraldehyde in 0.2 M-phosphate buffer, pH 7"2, and washed with the phosphate buffer. The bound peroxidase was then made visible according to the procedure of Graham & Karnovsky (2966) using 3,3'-diaminobenzidine tetrahydrochloride to develop the colour. The stained coverslips were dehydrated and mounted permanently on glass slides. Kabat & Mayer (I96I) were used to standardize reagents and to perform the tests, except that volumes for the test were adjusted to employ microtitre plates with a final vol. of o.I ml per test. Five CHso units of complement were used in the test.
Complement-fixation (CF) tests. The methods described by

Preparation of T antigen for CF tests.
Packed lyophilized whole cells (see below) were re-hydrated in veronal buffer (Kabat & Mayer, I960 , o'2 ml of cells in o.6 ml of buffer, ground in a glass tissue homogenizer and centrifuged at 25 ooo g for 20 min. The supernatant fluids were removed and stored at -7 o °C.
Absorption of antisera.
For absorption with T antigen, freshly trypsinized, virustransformed tissue culture cells were washed in TBS and 0.2 ml samples of packed cells were distributed in each of a series of tubes. The cells were centrifuged, the supernatant fluid removed and the cells lyophilized and stored at -20 °C. For absorption of sera, each 0-2 ml of packed cells was re-hydrated with I ml of distilled water, centrifuged at 2ooo g for 20 min and the cells resuspended in I ml of the serum to be absorbed, diluted i]Io in TBS. The suspension was incubated with frequent mixing at 37 °C for 2 h, centrifuged, and the absorbed serum removed. This procedure was repeated with additional cells until all reactivity in the immunoperoxidase test between the serum and cells used for absorption was removed. Prior to use in CF tests the absorbed sera were centrifuged at 25 ooo g for 2o rain in an attempt to remove anti-complementary activity caused by suspended antigenantibody complexes.
Origin of cell lines. The origins of the papovavirus-transformed cell lines used in this study are summarized in Table I . The BK-CS9, HJC-15 and SV4o-DAR cell lines were With the exception of the human VA-2 cell line, all were derived from Syrian hamsters and all of the hamster lines induced formation of tumours and T antibody when transplanted in that species. The VA-2 line was obtained by in vitro transformation of cultured human diploid buccal mucosa cells, and the RF-r94 line by in vitro transformation of a primary hamster embryo fibroblast cell culture. The others came from tumours induced by injection of virus into newborn hamsters either subcutaneously (BK-CS9) or intracranially (HJC-I5 and SV4o-DAR).
The viruses used to transform these cells include examples of three major subgroups of human papovaviruses (see introduction): BKV and RFV represent the BK subgroup, JCV represents the JC subgroub of PML-associated viruses, and SV4o-DAR (also referred to as PML-2) represents PML-derived SV4o strains. The virus used to transform VA-2 cells was SV4o of simian origin.
RESULTS
Immunoperoxidase tests
Antiserum against the hamster cell T antigens was obtained by transplantation of each cell line into hamsters, and the resulting antisera were tested for the presence of T antibody by IP and CF with fixed cells or antigen extracted from cells of the homologous and heterologous lines. A pool of non-immune hamster serum from 6 to 8 week old animals gave no reaction in IP tests with any of the papovavirus-transformed cell lines. Anti-T antisera were tested for specificity by reaction with hamster embryo fibroblasts and with a cell line from a Schmidt-Ruppin Rous sarcoma virus-induced hamster tumour. Most gave no IP reaction; occasional non-specific reactions were invariably cytoplasmic and were removed by absorption with tissue powders from any of several species (human, hamster, chicken).
The amount of antigen present in the different celll ines varied over a wide range. As judged by the intensity of the IP reaction, the relative amounts of antigen were VA-z > RFq94 > SV4o-DAR > HJC-I5 > BK-CS9. The amount of antigen detectable by IP in the BK-CS9 line was very low, at best < I ~ of nuclei were weakly positive Table 2 ; VA-/cells were most antigenic, RF-r94 and SV4o-DAR were strong antigens, HJC-I5 was weak but positive and no CF antigen was detected in BK-CS9. The 25 % packed cell extracts were not significantly anti-complementary. Because of their low antigenicity, BK-CS9 cells could not be used as antigen or absorbent in the experiments described below, however that cell line was immunogenic in hamsters and usable antisera against BK T antigen were obtained. Each antiserum was screened at a dilution of I[to by IP with homologous cells, taking RF-I94 cells as homologous to BK-CS9 antisera. Potent antisera were tested for cross reactivity with heterologous cells, and antisera that cross-reacted extensively were chosen for absorption. Each antiserum was diluted t/Io and samples were absorbed with each cell line (except BK-CS9) until no further IP reaction was detected with the cells used for absorption. Between 4 and 8 absorptions were required, depending on the potency of antibody and absorbent. Each absorbed antiserum was then tested for residual activity against homologous and heterologous antigens by IP and CF. The effect of these manipulations on reactivity of antisera with T antigen induced by infection of permissive cells was also examined. Coverslip cultures of HEK were infected with either BKV or RFV, and CV-I cells were infected with SV4o and the infected coverslip cultures were fixed for IP reactions after 4 to 5 days. The results of all of these tests are summarized in Tables 3 and 4- Immunoperoxidase reactions (Table 3) were graded on an arbitrary scale of + to + + + + indicating increasing intensity of reaction. Cells were scored + if any reaction was detected, a negative means that no positive nuclei were found after search of at least I I8 minx I8 mm coverglass (about IO 5 cells). The results with one set of reactions are illustrated in Fig. I . Unabsorbed antiserum against RFV T antigen, from a hamster with 5-2 R. M. DOUGHERTY an RF-I94 tumour, reacted with the T antigen of RF-I94 cells (Fig. I a, + + + + reaction) and slightly less intensely with SV4o-DAR cells (Fig. I b, + + + reaction) . The same antiserum, absorbed 6 times with lyophilized SV4o-DAR cells, reacted strongly with RF-I94 T antigen (Fig. I e, + + + reaction), but not at all with T antigen of SV4o-DAR (Fig. I d, -reaction) .
Absorption tests
Tests with unabsorbed antisera (Table 3 , row A) show that all of the antisera selected for these tests cross-reacted with all heterologous T antigens. There was no consistent evidence of preferential reaction with homologous antigen, though only the JC antiserum reacted strongly with JC antigen.
RF-194 cells proved to be the most effective absorbent (row B). All T antibody was removed from RFV and BKV antisera. Absorption of JCV antiserum with RF-I94 removed all cross-reacting antibody but left a significant homologous reaction, indicating that JCV T antigen is distinct from T antigens of SV4o and the urine derived papovaviruses BKV and RFV. Absorption of SV4o-DAR antiserum with RF-I94 removed all reactivity with RFV-or JCV-transformed cells and RFV-or BKV-infected permissive cells, but had no effect on the homologous reaction with SV4o-DAR-transformed cells, and only slightly reduced the reaction of SV4o-DAR antiserum with T antigen of SV4o-transformed VA-2 cells or SV4o-infected CV-I cells. This confirms the previous report that SV4 o and RFV T antigens are distinct (Dougherty, I976 ) . Absorption of antisera with HJC-I 5 cells (Table 3 , row C) confirmed that BKV and RFV T antigens are distinct from JCV T antigen and suggested that JCV T antigen may occupy an intermediate position relative to those of BKV and SV4o. Residual antibody remained in all but the homologous serum after absorption with H J C q 5 cells, which indicates that JCV T antigen has unique antigenic determinants. There was little, if any, effect on homologous or heterologous antibodies in RF-I94 antiserum after removal of all antibody reactive with HJC-~5. However, absorption of BKV antiserum with HJC-I5 cells removed most of the activity against SV4o-DAR and VA-2 and completely removed reaction with SV4o-infected CV-~ ceils, leaving antibody relatively unchanged against RF-t94 and RFV-or BKV-infected HEK. Conversely, absorption of SV4o-DAR serum with HJC-I 5 removed most activity against RFV-and BKV-transformed or infected cells but left SV4o reactions unaltered or slightly reduced. Thus, the HJC-I 5 antigen had affinity for the cross-reacting components in both BKV and SV4o-DAR antiserum. Antiserum against RFV T antigen appeared to cross-react more readily than BKV T antiserum, and this is confirmed below.
Absorption with SV4o-DAR cells (Table, 3 row D) removed all antibodies from the homologous serum and all cross reacting antibodies from BK-CS9 antiserum. Activity against T antigens of VA-2 and SV4o-infected CV-I cells remained in RF-I94 antiserum after adsorption with SV4o-DAR which indicates a difference between simian SV4o and human SV4o-DAR T antigens. Antibodies against VA-z and SV4o-infected CV-I antigens were removed from the BK antiserum, another indication of the broader reactivity of RF antiserum. Absorption with SV4o-DAR cells removed most cross-reacting antibody from the JC antiserum and also removed all antibodies in other sera that cross-reacted with JCV T antigen, further confirmation of the affinity of JCV and SV4o-DAR T antigens. Absorption with VA-2 cells (Table 3 , row E) removed all papovavirus T antibody from SV4o-DAR antiserum, and antibodies cross-reacting with T antigens of VA-2 cells and SV4o-infected CV-I cells were removed from the three human papovavirus antisera. However, cross-reacting antibodies against SV4o-DAR T antigen were not removed from antisera against RFV, BKV or JCV T antigens. It is important to recall that VA-2 cells contained the most T antigen and should have been the most effective absorbent. Thus, the T antigen of VA-z cells, which were transformed by SV4 o virus isolated from monkeys, differs from T antigen of SV4o-DAR, which was isolated from human brain. The reduction of cross-reacting antibody after absorption with VA-2 was greater with HJC-I5 antiserum than with either RF-~94 or BK-CS9 (compare rows A and E) which reinforces the indication that T antigen of JCV is more closely related to that of SV4o than is that of BKV.
Complement fixation tests
The same combination of tests described above was done by CF (Table 4) . CF tests were much less sensitive in detecting cross reactions with unabsorbed sera (Table 4 , row A) than were IP tests. Only the broadly reactive RF antiserum cross-reacted strongly with all heterologous antigens. All antisera showed preference for the homologous antigen and all but anti-RFV cross-reacted poorly, if at all, which tends to confirm that the various T antigens are different.
CF studies with absorbed sera were less rewarding. Although neither antigens (Table 2 ) nor unabsorbed antisera (Table 4 , row A) were appreciably anti-complementary, nearly all absorbed antisera were anti-complementary (Table 4 , rows B to E), presumably because soluble antigen-antibody complexes remained after removal of the absorbent by centrifugation. Thus, much of the data cannot be interpreted; nonetheless, what data there are support the IP results.
Absorption with RF-I94 cells (Table 4 , row B) removed all detectable T antibody from all antisera. The absorbed SV4o DAR-serum was anti-complementary at the same level as its homologous antibody titre, so the results were uninterpretable.
Absorption with HJC-I 5 cells (Table 4 , row C) left homologous T antibodies in RF and BK antiserum and cross-reacting T antibodies between RF antiserum and the two SV4o T antigens. Absorption with SV4o-DAR cells (Table 4 , row D) lowered homologous reactions with RFV and JCV T antisera and reduced all other reactions to background, as did absorption with VA-z cells.
DISCUSSION
The results of this investigation may be summarized by saying that the primate papovavirus T antigens tested are all related but each is distinct. The distinctions are of interest in that they illuminate the interrelationships of this family of viruses.
The T antigens of the two papovaviruses from human urine, BKV and RFV are identical or nearly so; the broader reactivity of antisera against the RFV-transformed cell line probably results from its greater antigenic potency. Several lines of evidence place the T antigen of JCV in an intermediate position between those of BKV strains and SV4 o. Crossreacting antibody against JCV T antigen was absorbed completely by both RFV-r94 and SV4o-DAR cells (but only partly by VA-2) and absorption with HJC-I5 decreased crossreacting antibody in both SV4o-DAR and BK-CS9 antisera. Absorption with VA-2 cells had a greater effect on both homologous and heterologous reactions of HJC-~5 antisera than on antisera against BKV or RFV T antigens. Thus, T antigen of JCV is more closely related to BKV T antigen and SV4o T antigen than the latter are to each other.
As expected, the human SV4o-DAR T antigen appears to be very similar to simian SV4o T antigen of VA-2 cells, but the two can clearly be separated. Antisera against RFV, BKV, and JCV-transformed cells all contained cross-reacting T antibody against SV4o-DAR that was not absorbed by VA-2 cells, the most potent of the T antigens examined. Furthermore, absorption with the less potent SV4o-DAR T antigen was more effective than VA-2 antigen in removing homologous and cross-reacting antibody from antisera against RFV, BKV and JCV T antigens. Thus, the T antigen of SV4o-DAR virus, which was isolated from human brain, is more closely related to T antigens of the human papovaviruses than is that of VA-2, a simian papovavirus T antigen. On the basis of these tests, the relationships of these primate papovavirus T antigens can be summarized by placing the viruses in the linear order: (BKV = RFV)-(JCV)-(SV4o -DAR)-(simian SV4o ).
A practical consequence of these observations is that with appropriate absorption, antisera may be prepared which react in immunoperoxidase or complement fixation tests only with specific T antigens. This is of special interest since T antigens related to SV4o have been described in human tumours (Soriano, Shelburne & G6kcen, r974; Weiss et al. I975) . Specific identification of the virus involved in human tumours might be possible with suitably absorbed antisera, although absorbed sera with weak residual activity (+ or + + IP reactions) would probably only be useful with tumour cells that contained large amounts of T antigen.
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